Gene · 3316
Papers3,243
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,243
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The pathology behind glaucoma: what we already know using omics technologies. | Neural Regen Res | 2023 | 37449630 | PubTator, text mining | PubMed |
| Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review. | Cancers (Basel) | 2023 | 37444523 | PubTator, text mining | PubMed |
| Mangiferin for the Management of Liver Diseases: A Review. | Foods | 2023 | 37444207 | PubTator, text mining | PubMed |
| Hypothermic oxygenated perfusion attenuates DCD liver ischemia-reperfusion injury by activating the JAK2/STAT3/HAX1 pathway to regulate endoplasmic reticulum stress. | Cell Mol Biol Lett | 2023 | 37438690 | PubTator, text mining | PubMed |
| Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance. | Adv Sci (Weinh) | 2023 | 37436087 | PubTator, text mining | PubMed |
| Enhanced osseointegration of drug eluting nanotubular dental implants: An in vitro and in vivo study. | Bioact Mater | 2023 | 37426894 | PubTator, text mining | PubMed |
| Orchestrated regulation of immune inflammation with cell therapy in pediatric acute liver injury. | Front Immunol | 2023 | 37426664 | PubTator, text mining | PubMed |
| Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis. | Noncoding RNA Res | 2023 | 37416747 | PubTator, text mining | PubMed |
| Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD): A Systematic Review. | Cureus | 2023 | 37404420 | PubTator, text mining | PubMed |
| Biomolecular phase separation in stress granule assembly and virus infection. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37401177 | PubTator, text mining | PubMed |
| Protein Biomarkers in Chronic Kidney Disease in Children-What Do We Know So Far? | J Clin Med | 2023 | 37373629 | PubTator, text mining | PubMed |
| Iodine-Biofortified Lettuce Can Promote Mitochondrial Dependent Pathway of Apoptosis in Human Gastrointestinal Cancer Cells. | Int J Mol Sci | 2023 | 37373017 | PubTator, text mining | PubMed |
| Serine/Threonine Protein Phosphatases 1 and 2A in Lung Endothelial Barrier Regulation. | Biomedicines | 2023 | 37371733 | PubTator, text mining | PubMed |
| Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats. | Front Cardiovasc Med | 2023 | 37363100 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals distinct adaptive molecular mechanism in the hippocampal CA3 from rats susceptible or not-susceptible to hyperthermia-induced seizures. | Sci Rep | 2023 | 37355705 | PubTator, text mining | PubMed |
| Facioscapulohumeral Muscular Dystrophy is Associated With Altered Myoblast Proteome Dynamics. | Mol Cell Proteomics | 2023 | 37353005 | PubTator, text mining | PubMed |
| A Review of the Use of Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy in Pediatric Patients. | Cancers (Basel) | 2023 | 37345152 | PubTator, text mining | PubMed |
| The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology. | Cancers (Basel) | 2023 | 37345019 | PubTator, text mining | PubMed |
| Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinoma. | Comput Struct Biotechnol J | 2023 | 37304004 | PubTator, text mining | PubMed |
| Plasma Bioscience and Medicine Molecular Research. | Int J Mol Sci | 2023 | 37298125 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3316/papers?page=11